Rigel Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $139.1M
Liabilities Breakdown FY2018
Total Liabilities: $29.2M
Asset Breakdown
Total Assets: $139.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $76.3M | 54.9% |
| Accounts Receivable | $4.1M | 2.9% |
| Inventory | $894.0K | 0.6% |
| Property, Plant & Equipment | $1.4M | 1.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $56.4M | 40.6% |
Liabilities Breakdown
Total Liabilities: $29.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.4M | 21.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $22.8M | 78.1% |